Search results for " Parris C."

showing 2 items of 2 documents

Prevalence of erectile dysfunction in male survivors of cancer: a systematic review and meta-analysis of cross-sectional studies.

2021

BackgroundPrevalence of erectile dysfunction (ED) in male survivors of cancer across cancer types has not been systematically analysed.AimTo estimate the prevalence of ED in all types of cancer and identify characteristics associated with ED in survivors of cancer.Design and settingSystematic review and meta-analysis (MA) of cross-sectional studies.MethodMEDLINE, CINAHL, PsycINFO, and EMBASE were searched, targeting reports published from inception to 1 February 2020. All retrospective or prospective studies reporting prevalence of ED in male patients with cancer and using a validated tool for detection of ED were included. A random-effects MA model was used to pool prevalence of ED as abso…

Malemedicine.medical_specialtyerectile dysfunctionCross-sectional studyprevalence030232 urology & nephrologyMEDLINECINAHLmeta-analysi03 medical and health sciences0302 clinical medicinesystematic reviewErectile dysfunction; Male cancer; Meta-analysis; Prevalence; Systematic reviewNeoplasmsInternal medicineHumanscancerMedicineProspective StudiesSurvivorsProspective cohort studyRetrospective Studiesbusiness.industryResearchCancermale cancermedicine.diseaseConfidence intervalmeta-analysisCross-Sectional StudiesErectile dysfunction030220 oncology & carcinogenesisMeta-analysisa systematic review and meta-analysis of cross-sectional studies.- The British journal of general practice : the journal of the Royal College of General Practitioners cilt.71 2021 [Pizzol D. Xiao T. Smith L. Sánchez G. F. L. Garolla A. Parris C. Barnett Y. Ilie P. C. Soysal P. Shin J. I. et al. -Prevalence of erectile dysfunction in male survivors of cancer]systematic review.Family Practicebusiness
researchProduct

Ejaculation Disorders in Male Patients with Cancer: A Systematic Review and Meta-Analysis of Prevalence

2021

PURPOSE: Ejaculatory dysfunction (EjD) and erectile dysfunction after cancer treatment are clinically important complications, but their exact prevalence by various kinds of cancer site and type of treatment is unknown. The aim of this systematic review and meta-analysis was to examine the available evidence and provide pooled estimates for prevalence of EjD and erectile dysfunction in relation to all cancer sites and identify characteristics associated with EjD in cancer patients. MATERIALS AND METHODS: We performed a systematic review and meta-analysis of cross-sectional and case-control studies. We searched 4 electronic databases (Medline®, CINAHL, PsychInfo and Embase®) until July 22, 2…

Retrograde ejaculationmedicine.medical_specialtyejaculationEjaculationbusiness.industryerectile dysfunctionUrologyprevalenceA Systematic Review and Meta-Analysis of Prevalence.- The Journal of urology 2021 [Pizzol D. Trott M. Grabovac I. Yang L. Barnett Y. Parris C. McDermott D. T. Veronese N. Kronbichler A. Ghayda R. A. et al. -Ejaculation Disorders in Male Patients With Cancer]neoplasmsCancermedicine.diseaseCancer treatmentmeta-analysisErectile dysfunctionMale patientInternal medicineMeta-analysisDry Orgasmmedicineejaculation erectile dysfunction meta-analysis neoplasms prevalence Erectile Dysfunction Humans Male NeoplasmsPrevalence Sexual Dysfunction Physiological Ejaculationbusiness
researchProduct